Critical redundant functions of the adapters Grb2 and Gads in platelet (hem)ITAM signaling in mice

References

• Stegner D, Nieswandt B. Platelet receptor signaling in thrombus formation. J Mol Med (Berlin, Germany) 2011;89:109–121. Epub 2010/ 11/09. doi:10.1007/s00109-010-0691-5.
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Bergmeier W, Schulte V, Rackebrandt K, Gessner JE, Zirngibl H. Expression and function of the mouse collagen receptor glycoprotein VI is strictly dependent on its association with the FcRgamma chain. J Biol Chem 2000;275:23998–24002. Epub 2000/ 05/29. doi:10.1074/jbc.M003803200.
   PubMed Web of Science ®Google Scholar
• Watson SP, Herbert JM, Pollitt AY. GPVI and CLEC-2 in hemostasis and vascular integrity. J Thromb Haemost 2010;8:1456–1467. Epub 2010/ 03/30. doi:10.1111/(ISSN)1538-7836.
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Stefanini L. Platelet ITAM signaling. Curr Opin Hematol 2013;20:445–450. Epub 2013/ 08/08. doi:10.1097/MOH.0b013e3283642267.
   PubMed Web of Science ®Google Scholar
• Boulaftali Y, Hess PR, Getz TM, Cholka A, Stolla M, Mackman N, Owens AP 3rd, Ware J, Kahn ML, Bergmeier W. Platelet ITAM signaling is critical for vascular integrity in inflammation. J Clin Invest 2013;123:908–916. Epub 2013/ 01/26. doi:10.1172/JCI65154.
   PubMed Web of Science ®Google Scholar
• Hagedorn I, Vogtle T, Nieswandt B. Arterial thrombus formation. Novel mechanisms and targets. Hamostaseologie 2010;30:127–135. Epub 2010/ 08/04. doi:10.1055/s-0037-1619045.
   PubMed Web of Science ®Google Scholar
• Lee RH, Bergmeier W. Platelet immunoreceptor tyrosine-based activation motif (ITAM) and hemITAM signaling and vascular integrity in inflammation and development. J Thromb Haemost 2016;14:645–654. Epub 2016/ 01/11. doi:10.1111/jth.13250.
   PubMed Web of Science ®Google Scholar
• Rayes J, Watson SP, Nieswandt B. Functional significance of the platelet immune receptors GPVI and CLEC-2. J Clin Invest 2019;129:12–23. Epub 2019/ 01/03. doi:10.1172/JCI122955.
   PubMed Web of Science ®Google Scholar
• Dutting S, Vogtle T, Morowski M, Schiessl S, Schafer CM, Watson SK, Hughes CE, Ackermann JA, Radtke D, Hermanns HM, et al. Growth factor receptor-bound protein 2 contributes to (hem)immunoreceptor tyrosine-based activation motif-mediated signaling in platelets. Circ Res 2014;114:444–453. Epub 2013/ 11/23. doi:10.1161/CIRCRESAHA.114.302670.
   PubMed Web of Science ®Google Scholar
• Hughes CE, Auger JM, McGlade J, Eble JA, Pearce AC, Watson SP. Differential roles for the adapters Gads and LAT in platelet activation by GPVI and CLEC-2. J Thromb Haemost 2008;6:2152–2159. Epub 2008/ 10/02. doi:10.1111/jth.2008.6.issue-12.
   PubMed Web of Science ®Google Scholar
• Stegner D, Haining EJ, Nieswandt B. Targeting glycoprotein VI and the immunoreceptor tyrosine-based activation motif signaling pathway. Arterioscler Thromb Vasc Biol 2014;34:1615–1620. Epub 2014/ 06/14. doi:10.1161/ATVBAHA.114.303408.
   PubMed Web of Science ®Google Scholar
• Boyanova D, Nilla S, Birschmann I, Dandekar T, Dittrich M. PlateletWeb: a systems biologic analysis of signaling networks in human platelets. Blood 2012;119:e22–34. Epub 2011/ 11/30. doi:10.1182/blood-2011-10-387308.
   PubMedGoogle Scholar
• Garcia A, Senis YA, Antrobus R, Hughes CE, Dwek RA, Watson SP, Zitzmann N. A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: involvement of G6f, a novel platelet Grb2-binding membrane adapter. Proteomics 2006;6:5332–5343. Epub 2006/ 08/31. doi:10.1002/pmic.200600299.
   PubMed Web of Science ®Google Scholar
• Zeiler M, Moser M, Mann M. Copy number analysis of the murine platelet proteome spanning the complete abundance range. Mol Cell Proteomics 2014;13:3435–3445. Epub 2014/ 09/11. doi:10.1074/mcp.M114.038513.
   PubMed Web of Science ®Google Scholar
• Balagopalan L, Coussens NP, Sherman E, Samelson LE, Sommers CL. The LAT story: a tale of cooperativity, coordination, and choreography. Cold Spring Harb Perspect Biol 2010;2:a005512. Epub 2010/ 07/09. doi:10.1101/cshperspect.a005512.
   PubMed Web of Science ®Google Scholar
• Liu SK, Berry DM, McGlade CJ. The role of Gads in hematopoietic cell signalling. Oncogene 2001;20:6284–6290. Epub 2001/ 10/19. doi:10.1038/sj.onc.1204771.
   PubMed Web of Science ®Google Scholar
• Pearce AC, Senis YA, Billadeau DD, Turner M, Watson SP, Vigorito E. Vav1 and vav3 have critical but redundant roles in mediating platelet activation by collagen. J Biol Chem 2004;279:53955–53962. Epub 2004/ 10/01. doi:10.1074/jbc.M410355200.
   PubMed Web of Science ®Google Scholar
• Cherpokova D, Bender M, Morowski M, Kraft P, Schuhmann MK, Akbar SM, Sultan CS, Hughes CE, Kleinschnitz C, Stoll G, et al. SLAP/SLAP2 prevent excessive platelet (hem)ITAM signaling in thrombosis and ischemic stroke in mice. Blood 2015;125:185–194. Epub 2014/ 10/11. doi:10.1182/blood-2014-06-580597.
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K, Inoue O, Frampton J, Watson SP. Murine GPVI stimulates weak integrin activation in PLCgamma2-/- platelets: involvement of PLCgamma1 and PI3-kinase. Blood 2003;102:1367–1373. Epub 2003/ 05/06. doi:10.1182/blood-2003-01-0029.
   PubMed Web of Science ®Google Scholar
• Atkinson BT, Ellmeier W, Watson SP. Tec regulates platelet activation by GPVI in the absence of Btk. Blood 2003;102:3592–3599. Epub 2003/ 07/05. doi:10.1182/blood-2003-04-1142.
   PubMed Web of Science ®Google Scholar
• Watson SP, Auger JM, McCarty OJ, Pearce AC. GPVI and integrin alphaIIb beta3 signaling in platelets. J Thromb Haemost 2005;3:1752–1762. Epub 2005/ 08/17. doi:10.1111/jth.2005.3.issue-8.
   PubMed Web of Science ®Google Scholar
• Gruner S, Prostredna M, Aktas B, Moers A, Schulte V, Krieg T, Offermanns S, Eckes B, Nieswandt B. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy. Circulation 2004;110:2946–2951. Epub 2004/ 10/27. doi:10.1161/01.CIR.0000146341.63677.3C.
   PubMed Web of Science ®Google Scholar
• Finney BA, Schweighoffer E, Navarro-Nunez L, Benezech C, Barone F, Hughes CE, Langan SA, Lowe KL, Pollitt AY, Mourao-Sa D, et al. CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development. Blood 2012;119:1747–1756. Epub 2011/ 12/22. doi:10.1182/blood-2011-09-380709.
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K, Inoue O, Ding G, Nishimura S, Hokamura K, Eto K, Kashiwagi H, Tomiyama Y, Yatomi Y, Umemura K, et al. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem 2010;285:24494–24507. Epub 2010/ 06/08. doi:10.1074/jbc.M110.130575.
   PubMed Web of Science ®Google Scholar
• Uhrin P, Zaujec J, Breuss JM, Olcaydu D, Chrenek P, Stockinger H, Fuertbauer E, Moser M, Haiko P, Fassler R, et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 2010;115:3997–4005. Epub 2010/ 01/30. doi:10.1182/blood-2009-04-216069.
   PubMed Web of Science ®Google Scholar
• Spalton JC, Mori J, Pollitt AY, Hughes CE, Eble JA, Watson SP. The novel Syk inhibitor R406 reveals mechanistic differences in the initiation of GPVI and CLEC-2 signaling in platelets. J Thromb Haemost 2009;7:1192–1199. Epub 2009/ 05/09. doi:10.1111/jth.2009.7.issue-7.
   PubMed Web of Science ®Google Scholar
• Saci A, Liu WQ, Vidal M, Garbay C, Rendu F, Bachelot-Loza C. Differential effect of the inhibition of Grb2-SH3 interactions in platelet activation induced by thrombin and by Fc receptor engagement. Biochem J 2002;363:717–725. Epub 2002/ 04/20. doi:10.1042/0264-6021:3630717.
   PubMed Web of Science ®Google Scholar
• Ozdener F, Dangelmaier C, Ashby B, Kunapuli SP, Daniel JL. Activation of phospholipase Cgamma2 by tyrosine phosphorylation. Mol Pharmacol 2002;62:672–679. Epub 2002/ 08/16. doi:10.1124/mol.62.3.672.
   PubMed Web of Science ®Google Scholar
• Judd BA, Myung PS, Obergfell A, Myers EE, Cheng AM, Watson SP, Pear WS, Allman D, Shattil SJ, Koretzky GA. Differential requirement for LAT and SLP-76 in GPVI versus T cell receptor signaling. J Exp Med 2002;195:705–717. Epub 2002/ 03/20. doi:10.1084/jem.20011583.
   PubMed Web of Science ®Google Scholar
• Pasquet JM, Gross B, Quek L, Asazuma N, Zhang W, Sommers CL, Schweighoffer E, Tybulewicz V, Judd B, Lee JR, et al. LAT is required for tyrosine phosphorylation of phospholipase cgamma2 and platelet activation by the collagen receptor GPVI. Mol Cell Biol 1999;19:8326–8334. Epub 1999/ 11/24. doi:10.1128/MCB.19.12.8326.
   PubMed Web of Science ®Google Scholar
• Abtahian F, Bezman N, Clemens R, Sebzda E, Cheng L, Shattil SJ, Kahn ML, Koretzky GA. Evidence for the requirement of ITAM domains but not SLP-76/Gads interaction for integrin signaling in hematopoietic cells. Mol Cell Biol 2006;26:6936–6949. Epub 2006/ 09/01. doi:10.1128/MCB.01040-06.
   PubMed Web of Science ®Google Scholar
• Boerth NJ, Sadler JJ, Bauer DE, Clements JL, Gheith SM, Koretzky GA. Recruitment of SLP-76 to the membrane and glycolipid-enriched membrane microdomains replaces the requirement for linker for activation of T cells in T cell receptor signaling. J Exp Med 2000;192:1047–1058. Epub 2000/ 10/04. doi:10.1084/jem.192.7.1047.
   PubMed Web of Science ®Google Scholar
• Ishiai M, Kurosaki M, Inabe K, Chan AC, Sugamura K, Kurosaki T. Involvement of LAT, Gads, and Grb2 in compartmentation of SLP-76 to the plasma membrane. J Exp Med 2000;192:847–856. Epub 2000/ 09/20. doi:10.1084/jem.192.6.847.
   PubMed Web of Science ®Google Scholar
• Dutting S, Bender M, Nieswandt B. Platelet GPVI: a target for antithrombotic therapy?! Trends Pharmacol Sci 2012;33:583–590. Epub 2012/ 08/21. doi:10.1016/j.tips.2012.07.004.
   PubMed Web of Science ®Google Scholar
• Bender M, May F, Lorenz V, Thielmann I, Hagedorn I, Finney BA, Vogtle T, Remer K, Braun A, Bosl M, et al. Combined in vivo depletion of glycoprotein VI and C-type lectin-like receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice. Arterioscler Thromb Vasc Biol 2013;33:926–934. Epub 2013/ 03/02. doi:10.1161/ATVBAHA.112.300672.
   PubMed Web of Science ®Google Scholar
• Kalia N, Auger JM, Atkinson B, Watson SP. Critical role of FcR gamma-chain, LAT, PLCgamma2 and thrombin in arteriolar thrombus formation upon mild, laser-induced endothelial injury in vivo. Microcirculation 2008;15:325–335. Epub 2008/ 05/09. doi:10.1080/10739680701728822.
   PubMed Web of Science ®Google Scholar
• van Eeuwijk JM, Stegner D, Lamb DJ, Kraft P, Beck S, Thielmann I, Kiefer F, Walzog B, Stoll G, Nieswandt B. The novel oral syk inhibitor, Bl1002494, protects mice from arterial thrombosis and thromboinflammatory brain infarction. Arterioscler Thromb Vasc Biol 2016;36:1247–1253. Epub 2016/ 04/23. doi:10.1161/ATVBAHA.115.306883.
   PubMed Web of Science ®Google Scholar
• Ackermann JA, Radtke D, Maurberger A, Winkler TH, Nitschke L. Grb2 regulates B-cell maturation, B-cell memory responses and inhibits B-cell Ca2+ signalling. Embo J 2011;30:1621–1633. Epub 2011/ 03/24. doi:10.1038/emboj.2011.74.
   PubMed Web of Science ®Google Scholar
• Jang IK, Cronshaw DG, Xie LK, Fang G, Zhang J, Oh H, Fu YX, Gu H, Zou Y. Growth-factor receptor-bound protein-2 (Grb2) signaling in B cells controls lymphoid follicle organization and germinal center reaction. Proc Natl Acad Sci U S A 2011;108:7926–7931. Epub 2011/ 04/22. doi:10.1073/pnas.1016451108.
   PubMed Web of Science ®Google Scholar